Clinical trials
Phase 3 trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6,870 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 66 |
| 2001 | 73 |
| 2002 | 98 |
| 2003 | 154 |
| 2004 | 185 |
| 2005 | 248 |
| 2006 | 288 |
| 2007 | 269 |
| 2008 | 312 |
| 2009 | 257 |
| 2010 | 282 |
| 2011 | 252 |
| 2012 | 279 |
| 2013 | 285 |
| 2014 | 292 |
| 2015 | 288 |
| 2016 | 259 |
| 2017 | 303 |
| 2018 | 322 |
| 2019 | 277 |
| 2020 | 267 |
| 2021 | 331 |
| 2022 | 259 |
| 2023 | 289 |
| 2024 | 270 |
| 2025 | 277 |
| 2026 | 192 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4,409 |
| Terminated | 784 |
| Active, not recruiting | 724 |
| Recruiting | 619 |
| Unknown status | 186 |
| Withdrawn | 62 |
| Not yet recruiting | 42 |
| Enrolling by invitation | 30 |
| Suspended | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 321 |
| Novartis Pharmaceuticals | 281 |
| Hoffmann-La Roche | 243 |
| Pfizer | 215 |
| Sanofi | 204 |
| GlaxoSmithKline | 198 |
| Eli Lilly and Company | 173 |
| Bristol-Myers Squibb | 153 |
| Boehringer Ingelheim | 138 |
| Amgen | 133 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 256 |
| Breast Neoplasms | 225 |
| Carcinoma, Non-Small-Cell Lung | 207 |
| Prostatic Neoplasms | 158 |
| Neoplasms | 150 |
| Diabetes Mellitus | 118 |
| Pulmonary Disease, Chronic Obstructive | 114 |
| Asthma | 102 |
| Alzheimer Disease | 96 |
| Neoplasm Metastasis | 95 |
Trials
Showing 1 to 25 of 6,870. Each trial links to its page on Pharma Observatory.
6,770 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.